EUCTR2006-001979-38-IT进行中（未招募）不适用
INTRAINDIVIDUAL CROSS-OVER STUDY TO COMPARE MULTIHANCE AND OMNISCAN AT A DOSE OF 0.1 MMOL/KGBW IN THE DIFFERENTIAL DIAGNOSIS OF DISC HERNIATION VS. SCAR - ND
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1. Patient had a disk surgery at the lumbosacral spine (between 3 weeks and 12 months before enrolment into this study) and suffers from clinical symptoms suggesting recurrent symptoms; 2. Patient is scheduled for MRI for differential diagnosis between herniated disk and scar (soft tissue) 3. Patient`s age is ≥ 18 years old; 4. Patient gave written Informed Consent to participate in the study and is willing to comply with protocol requirements.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1. Patient has a body weight  150 kg; 2. Patients with a severe heart failure (NYHA class IV); 3. Patient has undergone any intravascular MR contrast agent procedure within 48 hours preceding the first MR examination; 4. Patient with a history of hypersensitivity to any metals or to chelates of Gadolinium or to any ingredients of the two contrast agents; 5. Patients with a significant allergic disposition; 6. Patient with pacemakers, ferro-magnetic material such as surgical clips or any other conditions that would preclude proximity to a strong magnetic field; 7. Patient is suffering from severe claustrophobia; 8. Patient with any medical condition or other circumstances that would significantly decrease the chances of obtaining reliable data, achieving the study objectives, or completing the study and/or post-imaging follow-up examinations; 9. Patient is female and pregnant or nursing; 10. Patient is female and the possibility of pregnancy cannot be excluded from one of the following points: - surgical sterilization (method has to be recorded on medical history form), - confirmed post-menopausal (with minimum 1-year history without menstruation), - negative pregnancy test (confirmed via ß-HCG measurement); 11. Patient is currently participating or has previously participated in a study (in which an investigational drug was dispensed) within 30 days prior to admission to this study; 12. Patient has previously entered this study; 13. Patient without legal capacity (i.e. prisoners); 14. Patient has moderate to severe renal impairment defined as having GFR/eGFR < 60 mL/min
研究者
相似试验
进行中（未招募）
不适用
INTRAINDIVIDUAL CROSS-OVER STUDY TO COMPARE MULTIHANCE® AND MAGNEVIST® AT A DOSE OF 0.1 MMOL/KGBW IN CERVICO-CEREBRAL MR ANGIOGRAPHY AND CEREBRAL MR PERFUSION IMAGING AT 3 TESLA IN PATIENTS WITH CAROTID ARTERY STENOSISCarotid artery stenosisandscheduled for MRA, for MR perfusion examination and for an elective stent treatmentMedDRA version: 8.1Level: LLTClassification code 10007687Term: Carotid artery stenosisEUCTR2006-000929-59-DEBracco ALTANA Pharma GmbH
进行中（未招募）
不适用
INTRAINDIVIDUAL CROSS-OVER STUDY TO COMPARE MULTIHANCE® AND OMNISCAN® AT A DOSE OF 0.1 MMOL/KGBW IN THE DIFFERENTIAL DIAGNOSIS OF DISC HERNIATION VS. SCAR - MultiHance® vs. Omniscan® for Spinal DiseasesIntervertebral disc herniationMedDRA version: 8.1Level: LLTClassification code 10048856Term: Intervertebral disc herniationEUCTR2006-001979-38-DEBracco Imaging Deutschland GmbH
进行中（未招募）
不适用
Intra-individual cross-over comparison of MultiHance® and Vasovist® enhanced MRA of the Carotids - Vasovist MRA of the CarotidsPatients with at least one stenosis of one carotid artery of at least 90% as confirmed by Doppler ultrasound or other radiological methods who are scheduled for i.a. DSA for clinical reasons (or who have received i.a. DSA within 30 days of study inclusion)MedDRA version: 9.1Level: LLTClassification code 10007687Term: Carotid artery stenosisEUCTR2008-003669-24-DEDeutsches Krebsforschungszentrum
招募中
2 期
Prospective intra-individual comparison of the mpMRI versus 68Ga-PSMA11 PET/MRI in a blinded read to evaluate diagnostic accuracy in patients with prostate cancerD011471Prostate CancerJPRN-jRCTs022220021Kojima Yoshiyuki152
进行中（未招募）
不适用
Intraindividual cross-over study to compare 1.5-tesla and 3.0-tesla MRI with 0.05+0.05 mmol/kgbw MultiHance® in patients with Myocardial Infarctiomyocardial infarctionEUCTR2004-004084-29-DEBracco ALTANA Pharma GmbH